US: 1.917.963.8646 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Global Cervical Dysplasia Market 2021: By Diagnosis Type (Diagnostic Tests, HPV Test, Pap Smear Test, Biopsy Test, Diagnostic Devices, Colposcopy), By End-User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)Global Cervical Dysplasia Market is the title of an upcoming report offered by Trusted Business Insights. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in to various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global cervical dysplasia market has been segmented on the basis of diagnosis type, end-use, as well as regions and countries. The Global Cervical Dysplasia market size was valued at USD $473.81 Million in 2020, USD $507.46 Million in 2021, forecasted to reach USD $543.48 Million in 2022, and is projected to reach USD $943.64 Million by 2030, and is anticipated to expand at a CAGR of 7.1% over the forecast period from 2020 to 2030.
Overview:Cervical dysplasia is a precancerous condition in which abnormal cell growth occurs on the surface lining of the cervix or endocervical canal, the opening between the uterus and the vagina. It is also known as cervical intraepithelial neoplasia (CIN).
Dynamics:Due to the increasing prevalence of cervical dysplasia, as well as the significant increase in government funded cancer screening programs across the world are factors that are anticipated to continue to influence the revenue growth of the global cervical dysplasia market over the next 10 years. Moreover, the general increase in the occurrence of cancer across the world is another primary factor that is expected to have a profound influence on the future market growth of the global cervical dysplasia market in the foreseeable future. However, in light of the recent COVID-19 outbreak, the operations of numerous industries have been either temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global cervical dysplasia market is no different, and due to the same aforementioned reason, there has been a significant decline in the number of individuals either going to medical facilities to get themselves tested, as well as in the number of medical professionals presently working on improving diagnosis techniques since the beginning of this year. These are some of the factors that could potentially impede on the market growth of this global industry in the near future. Nonetheless, the steady increase in the number of awareness campaigns that focus specifically on the significance of early diagnoses being carried out by various respective organizations is also a factor that is slated to compliment the revenue growth of the global cervical dysplasia market in the years to come.
Segmentation of the global cervical dysplasia market is as follows:In terms of diagnosis type, the diagnostic tests segment accounted for the maximum number of revenue shares of the global cervical dysplasia market in 2020, and is expected to index considerable revenue growth over the next decade. This can be attributed to the cost-effectiveness, efficacy, flexibility, and favorable reimbursement policies these type of tests. With regards to end-use, the hospitals segment accounted for the highest number of revenue shares of the global cervical dysplasia market in 2020, and is expected to continue doing so in the years to come. This can be attributed to the presence of favorable reimbursement policies, as well as the wide availability of technologically innovative diagnostic devices at these facilities.
Regional Segmentation and Analysis:North America accounted for the highest number of revenue shares of the global cervical dysplasia market in 2020, and is expected to continue to do so over the course of this forecast period. This can be attributed to the implementation of various technological innovations, a significant increase in the number of screening programs being undertaken, as well as the number of initiatives being carried out by both private and government institutions in this region. The markets in Europe and the Asia Pacific regions are also anticipated to index considerable revenue growth over the next 10 years. SurePath™, Viper™, CellDetect®, careHPV™, are the brands covered in this Cervical Dysplasia report.
Below are the active patents related to Cervical Dysplasia Market.Patent Number: US20090269768A1 Detection of high grade dysplasia in cervical cells Abstract Methods of using probes and probe sets for the detection of high grade dysplasia and carcinoma in cervical cells are described. Methods of the invention include hybridizing one or more chromosomal probes to a biological sample obtained from a subject and detecting the hybridization pattern of the chromosomal probes to the sample to determine whether the subject has high grade dysplasia or carcinoma. Methods of the invention also include preliminary screening the cells for a marker associated with a risk for cancer, and preferably involves screening for HPV infected cells by in situ hybridization using an HPV probe mixture. Type: Grant Filed: 2009-04-13 Date of Patent: 2009-10-29 Assignee : Abbott Molecular Inc
Below are the leading companies profiled in this Cervical Dysplasia Market Report:
Chapter 1 Methodology and Scope